HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,182: | Line 1,182: | ||
| || | | || | ||
|- | |- | ||
|Cold agglutinin disease | |||
|Disease | |||
| | | | ||
| | | | ||
| Line 1,187: | Line 1,189: | ||
| | | | ||
| | | | ||
| | |SG | ||
| | | | ||
| | | | ||
| | | | ||
|- | |- | ||
| || || || || || || || || | |IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || || | |Non-IgM monoclonal gammopathy of undetermined significance||Disease|| || || || || ||SG|| | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Monoclonal gammopathy of renal significance||Disease|| || || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Immunoglobulin-related (AL) amyloidosis||Disease||Heather E. Williams, PhD, MS, PgD, ErCLG|| || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Monoclonal immunoglobulin deposition disease||Disease||Chen Yang, MD, PhD, University of Michigan|| || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Mu heavy chain disease||Disease|| || || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Gamma heavy chain disease||Disease||Manisha Brahmbhatt-Sutariya Asst. Professor, Dept. of Pathology and Human Anatomy Technical Supervisor, Clinical Genetics Laboratory Loma Linda University, Medical Center, CA|| || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Alpha heavy chain disease||Disease|| || || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Plasmacytoma||Disease|| || || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Plasma cell myeloma / multiple myeloma||Disease||*Huan Mo, MD, MS *Zhenya Tang, MD, PhD The University Of Texas MD Anderson Cancer Center, Department of Hematopathology, Houston, Texas|| || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |Plasma cell neoplasms with associated paraneoplastic syndrome||Disease||Sohini Anand, MBBS Tharanga Niroshini Senaratne, PhD|| || || || ||SG | ||
| | | | ||
| || | | || | ||
|- | |- | ||
| || || || || || || || | |CHAPTER 5 (T-CELL AND NK-CELL LYMPHOID PROLIFERATIONS AND LYMPHOMAS)|| | ||
----<br />|| | |||
----<br />|| || || || || | |||
| | | | ||
| || | | || | ||
| Line 1,379: | Line 1,381: | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| Line 1,412: | Line 1,412: | ||
| | | | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||
| | | || || || || || || || || | ||
| || | | || | ||
|- | |- | ||